Kiadis Pharma N.V. — Form D

Kiadis Pharma N.V. of AMSTERDAM, P7, a company, filed a Form D exempt-offering notice with the SEC on 2019-06-26. The offering totals $18.4M, of which $18.4M was reported sold. Industry: Biotechnology.

Offering

• Filed: 2019-06-26
• Form: D
• Accession: 0001567619-19-014020
• Industry: Biotechnology
• Exemptions: 06b
• Total offering: $18.4M
• Amount sold: $18.4M
• Investors: 25
• Date of first sale: 2019-06-05
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-342850

Issuer

• Name: Kiadis Pharma N.V.
• CIK: 0001780328
• Entity type: Limited Liability Company
• Jurisdiction: NETHERLANDS
• Incorporated: 2015
• Address: PAASHEUVELWEG 25A, AMSTERDAM, P7, 1105 BP
• Phone: 31 (0) 20 240 52 52

Officers, directors & promoters (10)

More

• CIK 1780328 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search